{"id":"NCT00329849","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age","officialTitle":"A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Compare the Safety of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With That of a Licensed Meningococcal ACWY Polysaccharide Vaccine (MenomuneÂ®) Administered to Healthy Children 2 to 10 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05","primaryCompletion":"2007-03","completion":"2007-03","firstPosted":"2006-05-25","resultsPosted":"2013-11-05","lastUpdate":"2018-10-09"},"enrollment":1500,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal ACWY-CRM conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Meningococcal ACWY-PS polysaccharide vaccine","otherNames":[]}],"arms":[{"label":"MenACWY-CRM","type":"EXPERIMENTAL"},{"label":"MenACWY-PS","type":"ACTIVE_COMPARATOR"}],"summary":"Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccharide vaccine in children 2 to 10 years of age","primaryOutcome":{"measure":"Percentage of Subjects With hSBA Seroresponse Against Serogroups A, C, W and Y One Month After Vaccination With MenACWY-CRM or MenACWY-PS","timeFrame":"1 month after vaccination (day 29)","effectByArm":[{"arm":"MenACWY-CRM","deltaMin":93,"sd":null},{"arm":"MenACWY-PS","deltaMin":55,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":21},"locations":{"siteCount":3,"countries":["Argentina"]},"refs":{"pmids":["19895922"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":950},"commonTop":["Injection site pain","Injection site erythema","Injection site induration","Headache","Pyrexia"]}}